Author

Craig Rogers

Henry Ford Health

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:protein structure prediction· 1 Approach:statistical model· 1

Frequent Co-Authors

Arie Belldegrun· 1 shared Bin Tean TehiD· 1 shared Brian Lane· 1 shared David Nicol· 1 shared Hiro-omi Kanayama· 1 shared Hyung Kim· 1 shared Jagadananda Ghosh· 1 shared Jitender MongaiD· 1 shared

Activity by Year

2017-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Arie Belldegrun

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

HF-125, a first-in-class computer-modeled novel inhibitor of Tribbles 2, for therapy of enzalutamide resistant, neuroendocrine prostate cancer.

Sougata Ghosh Chowdhury, Pritam Biswas, Jitender Monga, Steve Brown, Craig Rogers, Jagadananda Ghosh

This paper designs HF-125, a TRIB2 inhibitor, using AI-based modeling to treat enzalutamide-resistant neuroendocrine prostate cancer.

bioRxiv · Apr 30, 2026 · PreprintCancer Biology

Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma

Xiaona Wei, Yukti Choudhury, Weng Khong Lim, John Anema, Richard Kahnoski, Brian Lane, John Ludlow, Masayuki Takahashi, Hiro-omi Kanayama, Arie Belldegrun, Hyung Kim, Craig Rogers, David Nicol, Bin Tean Teh, Min-Han Tan

The paper develops a continuous gene expression score (CLEAR) for clear cell renal cell carcinoma that outperforms discrete subtypes in prognostic accuracy and treatment outcome correlation.

Scientific Reports · Aug 4, 2017Peer-reviewedCancer Biology